OUTLOOK THERAPEUTICS INC (OTLK)

OUTLOOK THERAPEUTICS INC (OTLK) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $127M; returns 1 day -7.8%, 1 week +6.4%, 1 year -60.1%.

Outlook Therapeutics, Inc. (OTLK) is a biopharmaceutical company focused on developing and commercializing bevacizumab-based therapies for retinal diseases.

Groups OTLK belongs to

• Biotechnology
• Ophthalmology
• Biopharmaceutical
• Commercial Stage Biotech
• Healthcare
• Life Sciences
• Monoclonal Antibodies
• Pharmaceuticals

OTLK financial model: income statement, cash flow and balance sheet